Isagenix International Opens Gilbert, Arizona, World Headquarters
03/09/2016
"We started Isagenix 14 years ago out of nearby Scottsdale," said Jim Coover, Isagenix Co-Founder/CEO. "We're thrilled with our new global headquarters where we can continue to contribute to local economic growth. Gilbert is a wonderful, thriving community within the greater Phoenix area and is a great location where we can continue to grow and positively impact world health."
According to company officials, employee wellness is the focus of the state-of-the-art facility located at 155 E. Rivulon Blvd. Exterior glass walls decrease the need for electricity and provide natural daylight. Additional amenities include a 300-seat auditorium and technologically advanced laboratories dedicated to developing new food and health products.
"On behalf of the state of Arizona, the greater Phoenix area, the Phoenix East Valley region, and the community of Gilbert, we are excited to hand Isagenix the key to the city and welcome its team to the Gilbert community," said Gilbert Mayor John Lewis.
Project Announcements
Annandale Millwork and Allied Systems Plans Newport News, Virginia, Operations
02/17/2026
Swiss-Based Georg Utz Plans Sumter, South Carolina, Packaging Operations
02/15/2026
GE Aerospace Expands Muskegon County, Michigan, Operations
02/15/2026
Global Polymers Plans Charlestown, Indiana, Headquarters Operations
02/15/2026
British-Based ARM Inc. Expands Austin, Texas, Operations
02/15/2026
Becton, Dickinson and Company Expands Columbus, Nebraska, Operations
02/15/2026
Most Read
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
Data Centers in 2025: When Power Became the Gatekeeper
Q4 2025
-
Speed Built In—The Real Differentiator for 2026 Site Selection Projects
Q1 2026
-
Preparing for the Next USMCA Shake-Up
Q4 2025
-
The New Industrial Revolution in Biotech
Q4 2025
-
Strategic Industries at the Crossroads: Defense, Aerospace, and Maritime Enter 2026
Q1 2026
-
The Skilled Trades Are Ready for a Digital Future
Q4 2025